A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup with $36M raised to design antibody drugs against pathogens, including AI-enabled bioweapons (Georgia Wells/Wall Street Journal)
Red Queen Bio is using artificial intelligence to design antibody drugs for novel pathogens—before future AI systems create them
We haven't written up this one. Techmeme has the full story — the link below goes straight to it.